Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer

Infectious Agents and Cancer

Volumn 5, Issue 1, 2010, Pages

  Smith, Elaine M ^a   Rubenstein, Linda M ^a   Hoffman, Henry ^b   Haugen, Thomas H ^b   Turek, Lubomir P ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PROTEIN P16; PROTEIN P53; TUMOR MARKER; VIRUS DNA;

ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WART VIRUS;

EID: 77949450418     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-5-4     Document Type: Article

References (29)

1. SEER Cancer Statistics Review, 1975-2001. L Ries M Eisner C Kosary BF Hankey BA Miller L Clegg A Mariotto EJ Feuer BK Edwards (eds), Bethesda, MD: National Cancer Institute 2004
2. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. DJ Haraf E Nodzenski D Brachman R Mick A Montag D Graves EE Vokes RR Weichselbaum, Clin Cancer Res 1996 2 755 62 9816227
3. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. EM Smith JM Ritchie KF Summersgill HT Hoffman DH Wang TH Haugen LP Turek, J Natl Cancer Inst 2004 96 449 55 15026470
4. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. T Andl T Kahn A Pfuhl T Nicola R Erber C Conradt W Klein M Helbig A Dietz H Weidauer FX Bosch, Cancer Res 1998 58 5 13 9426048
5. The RB and p53 pathways in cancer. CJ Sherr F McCormick, Cancer Cell 2002 2 103 12 10.1016/S1535-6108(02)00102-2 12204530
6. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. W Li CH Thompson CJ O'Brien EB McNeil RA Scolyer YE Cossart MJ Veness DM Walker GJ Morgan BR Rose, Int J Cancer 2003 106 553 8 10.1002/ijc.11261 12845651
7. p16(INK4a) Expression, human papillomavirus, and survival in head and neck cancer. EM Smith D Wang Y Kim LM Rubenstein JH Lee TH Haugen LP Turek, Oral Oncol 2008 44 133 142 10.1016/j.oraloncology.2007.01.010 17360226
8. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. SA Geisler AF Olshan MC Weissler J Cai WK Funkhouser J Smith K Vick, Clin Cancer Res 2002 8 3445 53 12429633
9. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. JP Klussmann E Gultekin SJ Weissenborn U Wieland V Dries HP Dienes HE Eckel HJ Pfister PG Fuchs, Am J Pathol 2003 162 747 53 12598309
10. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. JM Ritchie EM Smith KF Summersgill HT Hoffman D Wang JP Klussmann LP Turek TH Haugen, Int J Cancer 2003 104 336 344 10.1002/ijc.10960 12569557
11. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. RJ Bova DI Quinn JS Nankervis IE Cole BF Sheridan MJ Jensen GJ Morgan CJ Hughes RL Sutherland, Clin Cancer Res 1999 5 2810 9 10537346
12. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. AF Olshan MC Weissler H Pei K Conway S Anderson DB Fried WG Yarbrough, Oncogene 1997 14 811 8 10.1038/sj.onc.1200892 9047388
13. Association between p53 and human papillomavirus in head and neck cancer curvival. EM Smith D Wang LM Rubenstein Morris WA LP Turek TH Haugen, Cancer Epidemiol Biomark Prev 2008 17 421 7 10.1158/1055-9965.EPI-07-2597
14. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. JA Brennan L Mao RH Hruban JO Boyle YJ Eby WM Koch SN Goodman D Sidransky, N Engl J Med 1995 332 429 35 10.1056/ NEJM199502163320704 7619114
15. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. EA Sisk SG Soltys S Zhu SG Fisher TE Carey CR Bradford, Head Neck 2002 24 841 9 10.1002/hed.10146 12211048
16. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. ML Gillison WM Koch RB Capone M Spafford WH Westra L Wu ML Zahurak RW Daniel M Viglione DE Symer KV Shah D Sidransky, J Natl Cancer Inst 2000 92 709 20 10.1093/jnci/92.9.709 10793107
17. The role of TP53 in Cervical carcinogenesis. M Tommasino R Accardi S Caldeira W Dong I Malanchi A Smet I Zehbe, Hum Mutat 2003 21 307 12 10.1002/humu.10178 12619117
18. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. PM Weinberger Z Yu BG Haffty D Kowalski M Harigopal J Brandsma C Sasaki J Joe RL Camp DL Rimm A Psyrri, J Clin Oncol 2006 24 736 47 10.1200/JCO.2004.00.3335 16401683
19. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. L Licitra F Perrone P Bossi S Suardi L Mariani R Artusi M Oggionni C Rossini G Cantu M Squadrelli P Quattrone LD Locati C Bergamini P Olmi MA Pierotti S Pilotti, J Clin Oncol 2006 24 5630 6 10.1200/JCO.2005.04.6136 17179101
20. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. ML Gillison G D'Souza W Westra E Sugar W Xiao S Begum R Viscidi, J Natl Cancer Inst 2008 100 407 420 10.1093/jnci/djn025 18334711
21. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. KM Applebaum CS Furniss A Zeka MR Posner JF Smith J Bryan EA Eisen ES Peters MD McClean KT Kelsey, J Natl Cancer Inst 2007 99 1801 10 10.1093/jnci/djm233 18042931
22. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. F Perrone S Suardi E Pastore P Casieri M Orsenigo S Caramuta G Dagrada M Losa L Licitra P Bossi S Staurengo M Oggionni L Locati G Cantu M Squadrelli A Carbone MA Pierotti S Pilotti, Clin Cancer Res 2006 12 6643 51 10.1158/1078-0432.CCR-06-1759 17121883
23. EGFR, p16, HPV titer, Bcl-xL, and p53, sex, and smoking as indicators of response to therapy and surival in oropharyngeal cancer. B Kuman KG Cordell JS Lee FP Worden ME Prince HH Tran GT Wolf SG Urba DB Chepeha TN Teknos A Eisbruch CI Tsien JM Taylor NJ D'Silva K Yang DM Kurnit JA Bauer CR Bradford TE Carey, J Clin Oncol 2008 26 3128 3137 10.1200/JCO.2007.12.7662 18474878
24. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. HC Halfkamp EJ Speel A Haesevoets FJ Bot WN Dinjens FC Ramaekers AH Hopman JJ Manni, J Natl Cancer Instit 2003 107 394 400
25. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. HC Hafkamp JJ Mooren SM Claessen B Klingenberg AC Voogd FJ Bot JP Klussmann AH Hopman JJ Manni B Kremer FC Ramaekers EJ Speel, Mod Pathol 2009 22 686 98 10.1038/modpathol.2009.23 19305381
26. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. N Reimers HU Kasper SJ Weissenborn H Stützer SF Preuss TK Hoffmann EJ Speel HP Dienes HJ Pfister O Guntinas-Lichius JP Klussmann, Int J Cancer 2007 120 1731 8 10.1002/ijc.22355 17236202
27. American Joint Committee on Cancer. AJCC Cancer Staging Manual. ID Fleming JS Cooper DE Henson RVP Hutter BJ Kennedy GP Murphy B O'Sullivan LH Sobin JW Yarbo eds, Philadelphia: Lippincott Williams & Wilkins 1997
28. SEER Cancer Statistics Review, 1973-1999 vol. 2006. L Ries M Eisner C Kosary BF Hankey BA Miller (eds), Bethesda, MD.: National Cancer Institute 2002
29. National Death Index, vol. 2006. National Center for Health Statistics http://www.cdc.gov/nchs/ndi.htm